Screener
Ionis Pharmaceuticals IONS Unrealized Losses on Investments (Before Tax)
Unrealized Losses on Investments (Before Tax) at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax.
The source filing: Ionis Pharmaceuticals’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 5:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000874015-26-000251
| June 30, 2026 | Amortized / Cost | Gross Unrealized / Gains | Gross Unrealized / Losses | Estimated / Fair Value |
|---|---|---|---|---|
| Debt securities issued by the U.S. Treasury | 181,168 | - | (1,340) | 179,828 |
| Debt securities issued by states of the U.S. and political subdivisions of the states | 731 | - | (1) | 730 |
| Total debt securities with a maturity of more than one year | 651,145 | 91 | (3,911) | 647,325 |
| Total available-for-sale debt securities | $$1,788,862 | $516 | $(5,012) | 1,784,366 |
| Equity securities: | ||||
| Publicly traded equity securities included in other current assets (2) | $$11,897 | $45,670 | $(9,799) | 47,768 |
| Privately held equity securities included in deposits and other assets (3) | 10,000 | 9,816 | - | 19,816 |
| Total equity securities | 21,897 | 55,486 | (9,799) | 67,584 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Ionis Pharmaceuticals's unrealized losses on investments (before tax)?
- Ionis Pharmaceuticals (IONS) reported unrealized losses on investments (before tax) of $5.01M in Q2 2026.
- How has Ionis Pharmaceuticals's unrealized losses on investments (before tax) changed year-over-year?
- Ionis Pharmaceuticals's unrealized losses on investments (before tax) increased by 266.9% year-over-year, from $1.37M to $5.01M.
- What is the long-term trend for Ionis Pharmaceuticals's unrealized losses on investments (before tax)?
- Over 4 years (2021 to 2025), Ionis Pharmaceuticals's unrealized losses on investments (before tax) has grown at a -51.1% compound annual growth rate (CAGR), from $4.31M to $246K.
- What does unrealized losses on investments (before tax) mean?
- This represents the cumulative negative difference between the current fair market value and the carrying value of available-for-sale debt securities before tax effects. It reflects the paper loss on the investment portfolio due to market interest rate fluctuations or credit risk changes. Monitoring this is essential for understanding potential balance sheet volatility related to treasury assets.
Ask your AI about Ionis Pharmaceuticals's unrealized losses on investments (before tax).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude